NUVB
Nuvation Bio Inc.NYSEHealthcare$4.41-2.22%ClosedMarket Cap: $1.53B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
5.01
P/S
24.52
EV/EBITDA
-7.09
DCF Value
$3.31
FCF Yield
-11.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
86.6%
Operating Margin
-338.7%
Net Margin
-325.3%
ROE
-57.5%
ROA
-34.4%
ROIC
-41.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $41.9M | 99.0% | $-34.0M | $-36.6M | $-0.11 | — |
| FY 2025 | $62.9M | 86.6% | $-213.1M | $-204.6M | $-0.60 | — |
| Q3 2025 | $13.1M | 74.5% | $-56.4M | $-55.8M | $-0.16 | — |
| Q2 2025 | $4.8M | 46.7% | $-63.6M | $-59.0M | $-0.17 | — |
| Q1 2025 | $3.1M | 32.1% | $-59.0M | $-53.2M | $-0.16 | — |
| Q4 2024 | $5.7M | 26.2% | $-53.9M | $-49.4M | $-0.15 | — |
| FY 2024 | $7.9M | 10.1% | $-592.6M | $-567.9M | $-2.11 | — |
| Q3 2024 | $727.0K | -108.4% | $-48.1M | $-41.2M | $-0.15 | — |
| Q2 2024 | $1.4M | 6.1% | $-470.4M | $-462.5M | $-1.89 | — |
| Q1 2024 | $0.00 | NaN% | $-20.2M | $-14.8M | $-0.07 | — |
| Q4 2023 | $0.00 | NaN% | $-20.8M | $-13.8M | $-0.06 | — |
| FY 2023 | $0.00 | NaN% | $-99.8M | $-75.8M | $-0.35 | — |